Warning: Undefined variable $zfal in C:\Inetpub\vhosts\kidney.de\httpdocs\mlpefetch.php on line 525
Deprecated: str_replace(): Passing null to parameter #3 ($subject) of type array|string is deprecated in C:\Inetpub\vhosts\kidney.de\httpdocs\mlpefetch.php on line 525
Warning: Undefined variable $sterm in C:\Inetpub\vhosts\kidney.de\httpdocs\mlpefetch.php on line 530
 free
Warning: Undefined variable $sterm in C:\Inetpub\vhosts\kidney.de\httpdocs\mlpefetch.php on line 531
 free
 free
 
English Wikipedia
Nephropedia Template TP (
Twit Text
DeepDyve
Pubget Overpricing |  
l�ll
Endothelial dysfunction: cardiovascular risk factors, therapy, and outcome Hadi HA; Carr CS; Al Suwaidi JVasc Health Risk Manag 2005[]; 1 (3): 183-98Endothelial dysfunction is a well established response to cardiovascular risk factors and precedes the development of atherosclerosis. Endothelial dysfunction is involved in lesion formation by the promotion of both the early and late mechanisms of atherosclerosis including up-regulation of adhesion molecules, increased chemokine secretion and leukocyte adherence, increased cell permeability, enhanced low-density lipoprotein oxidation, platelet activation, cytokine elaboration, and vascular smooth muscle cell proliferation and migration. Endothelial dysfunction is a term that covers diminished production/availability of nitric oxide and/or an imbalance in the relative contribution of endothelium-derived relaxing and contracting factors. Also, when cardiovascular risk factors are treated the endothelial dysfunction is reversed and it is an independent predictor of cardiac events. We review the literature concerning endothelial dysfunction in regard to its pathogenesis, treatment, and outcome.|*Vasodilation[MESH]|Aging/physiology[MESH]|Angiotensin-Converting Enzyme Inhibitors/therapeutic use[MESH]|Atherosclerosis/complications/*drug therapy/*physiopathology[MESH]|Brachial Artery/drug effects/physiopathology[MESH]|Cardiovascular Diseases/*etiology/prevention & control[MESH]|Coronary Circulation[MESH]|Diabetes Mellitus, Type 1/complications/physiopathology[MESH]|Diabetes Mellitus, Type 2/complications/physiopathology[MESH]|Endothelium, Vascular/*physiopathology[MESH]|Humans[MESH]|Hypercholesterolemia/complications/physiopathology[MESH]|Hyperhomocysteinemia/complications/physiopathology[MESH]|Hypertension/complications/physiopathology[MESH]|Hypoglycemic Agents/therapeutic use[MESH]|Hypolipidemic Agents/therapeutic use[MESH]|Kidney Failure, Chronic/physiopathology[MESH]|Obesity/complications/physiopathology[MESH]|Prognosis[MESH]|Risk Factors[MESH]|Smoking/physiopathology[MESH]|Treatment Outcome[MESH] |